0 0 0.00171874999999999 0.0358515625 0.021015625 0.0224609375 0.0308984375000001 0.034375
Sign Up Today X
Thanks for submitting the form.
Stockreport

Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida [Yahoo! Finance]

Illumina, Inc. (ILMN)  More Company Research Source: Yahoo! Finance
Last illumina, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
SAN DIEGO Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new Diagnostic Lab at Florida Institute for Pediatric Rare Diseases (IPRD) at Florida State University (FSU) College of Medicine, further driving innovation in diagnostics and treatments for rare diseases. Cynthia Vied, PhD, scientific director, IPRD Diagnostic Lab at FSU College of Medicine "An estimated 30 million people across the country are living with a rare disease today and clinical whole-genome testing provides a transformative opportunity to end the diagnostic odyssey for patients," said Eric Green, MD, PhD, chief medical officer of Illumina. "Our colleagues at IPRD will now be equipped to break diagnostic barriers, and we are proud to help them accelerate making life-saving discoveries." Diagnosing rare genetic diseases is challenging—advanced [Read more]
IMPACT SNAPSHOT EVENT TIME: ILMN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ILMN alerts
from News Quantified
ILMN
NEWS
ILMN
Earnings
ILMN
Analyst Actions
ILMN
SEC Filings
Stockreport

Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida [Yahoo! Finance]

Illumina, Inc.  (ILMN) 
More Company Research Source: Yahoo! Finance
Last illumina, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
SAN DIEGO Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new Diagnostic Lab at Florida Institute for Pediatric Rare Diseases (IPRD) at Florida State University (FSU) College of Medicine, further driving innovation in diagnostics and treatments for rare diseases. Cynthia Vied, PhD, scientific director, IPRD Diagnostic Lab at FSU College of Medicine "An estimated 30 million people across the country are living with a rare disease today and clinical whole-genome testing provides a transformative opportunity to end the diagnostic odyssey for patients," said Eric Green, MD, PhD, chief medical officer of Illumina. "Our colleagues at IPRD will now be equipped to break diagnostic barriers, and we are proud to help them accelerate making life-saving discoveries." Diagnosing rare genetic diseases is challenging—advanced [Read more]
IMPACT SNAPSHOT
EVENT TIME:
ILMN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS